Growth Highlights: Recent analyses on social media underscore Ryan Specialty's standout performance, with the company posting 10.1% organic growth for fiscal 2025, outpacing peers in the insurance brokerage sector. Observers note this metric positions it favorably against competitors trading at varied multiples.
Insider Moves: Executives have taken notable actions, including the chief financial officer purchasing shares worth $200,000 in an open-market transaction, marking the first such buy in over a year. Another senior leader also acquired shares, signaling heightened internal confidence amid recent price fluctuations.
Fund Interest: Institutional players are drawing attention for increasing positions in the stock despite broader market pressures, with one fund adding millions in exposure. Discussions highlight the contrast between the firm's consistent revenue expansion and its share price trajectory over the past year.
Note: This discussion summary was generated from an AI condensation of post data.
Ryan Specialty Insider Trading Activity
Ryan Specialty insiders have traded $RYAN stock on the open market 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $RYAN stock by insiders over the last 6 months:
- CORP ONEX sold 4,145,621 shares for an estimated $225,936,344
- TIMOTHY WILLIAM TURNER (Chief Executive Officer) sold 129,570 shares for an estimated $6,946,247
- PATRICK G JR RYAN has made 3 purchases buying 25,865 shares for an estimated $1,033,974 and 0 sales.
- JANICE M HAMILTON (Chief Financial Officer) purchased 6,300 shares for an estimated $200,292
- MARK STEPHEN KATZ (EVP & General Counsel) purchased 3,215 shares for an estimated $99,888
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Ryan Specialty Revenue
Ryan Specialty had revenues of $795.2M in Q1 2026. This is an increase of 15.22% from the same period in the prior year.
You can track RYAN financials on Quiver Quantitative's RYAN stock page.
You can access data on RYAN stock through the Quiver Quantitative API.
Ryan Specialty Hedge Fund Activity
We have seen 208 institutional investors add shares of Ryan Specialty stock to their portfolio, and 242 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 6,640,638 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $224,055,126
- BANK OF MONTREAL /CAN/ added 2,276,075 shares (+19288.8%) to their portfolio in Q1 2026, for an estimated $76,794,770
- NEUBERGER BERMAN GROUP LLC added 2,241,285 shares (+259.3%) to their portfolio in Q1 2026, for an estimated $75,620,955
- VULCAN VALUE PARTNERS, LLC added 1,974,256 shares (+42.7%) to their portfolio in Q1 2026, for an estimated $66,611,397
- VIKING GLOBAL INVESTORS LP removed 1,934,957 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $99,901,829
- RAYMOND JAMES FINANCIAL INC removed 1,106,527 shares (-92.1%) from their portfolio in Q1 2026, for an estimated $37,334,220
- KENSICO CAPITAL MANAGEMENT CORP removed 959,500 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $32,373,530
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Ryan Specialty Analyst Ratings
Wall Street analysts have issued reports on $RYAN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/08/2026
To track analyst ratings and price targets for Ryan Specialty, check out Quiver Quantitative's $RYAN forecast page.
Ryan Specialty Price Targets
Multiple analysts have issued price targets for $RYAN recently. We have seen 15 analysts offer price targets for $RYAN in the last 6 months, with a median target of $43.0.
Here are some recent targets:
- Bob Huang from Morgan Stanley set a target price of $39.0 on 05/21/2026
- Matthew Heimermann from Citigroup set a target price of $50.0 on 05/04/2026
- Brian Meredith from UBS set a target price of $51.0 on 05/04/2026
- Elyse Greenspan from Wells Fargo set a target price of $31.0 on 05/01/2026
- Alex Scott from Barclays set a target price of $39.0 on 05/01/2026
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $42.0 on 05/01/2026
- Paul Newsome from Piper Sandler set a target price of $35.0 on 05/01/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
